Jan Hansel
University of Manchester
Research areas: Medicine · Anesthesiology and Pain Medicine · Airway Management and Intubation Techniques · Anesthesia and Sedative Agents · Tracheal and airway disorders
0000-0003-2858-1313
About
NIHR Doctoral Fellow in Intensive Care Medicine
Clinical Research Fellow, The University of Manchester
Intensive Care Medicine/Anaesthetics Registrar, North West UK
Jan Hansel is an NIHR Doctoral Fellow in Intensive Care Medicine at The University of Manchester with an honorary contract at Manchester University NHS Foundation Trust. His research focuses on precision methods in sepsis antimicrobial therapy and airway management.
He graduated from The University of Maribor in 2015 and pursued clinical training in emergency medicine in Reykjavík, Iceland. In 2019 he commenced anaesthetics training in the North West of England, and is currently a dual trainee in Intensive Care Medicine and Anaesthetics. He completed an NIHR Academic Clinical Fellowship in 2024. He was awarded an externally funded PhD fellowship through the NIHR's Doctoral Fellowship programme to investigate the interaction between sepsis phenotypes and antimicrobial pharmacokinetics in critically ill patients.
He has published over 45 peer-reviewed publications and has an H-index of 12 on Google Scholar. He was the principal author of an impactful Cochrane systematic review looking at devices used for tracheal intubation in adults in 2022, which has informed multiple clinical practice guidelines. He is a member of the steering committee for the Airway Terminology and Outcome Measures group, which is funded by the Association of Anaesthetists through the National Institute of Academic Anaesthesia. He is a regular peer reviewer for CHEST, Cochrane, BJA, JICS, BMJ Open, BMC Medical Education and Trends in Anaesthesia and Critical Care. He is actively involved in the Trainee Research in Intensive Care (TRIC) network in the UK, and has helped deliver a number of multicentre projects.
He was the principal investigator of the TDM-TIME Study, looking at timing of therapeutic drug monitoring of beta-lactam antimicrobials in critical care, for which he has received a New Investigator Award from the Intensive Care Society. Currently, he is the Chief Investigator of the SIPRES Study, sponsored by The University of Manchester and funded by an NIHR Doctoral Fellowship, which is due to start recruitment at Manchester University NHS Foundation Trust in 2025.
Employment
Education
Projects & Funding
Projects & funding information is unavailable.
Publications (49)
- Awake tracheal intubation as a high‐acuity, low‐occurrence event: is widespread videolaryngoscopy to blame? Save
- Prevalence of respiratory viruses in stable and acute asthma Save
- A core outcome set for airway management research Save
- A prospective cohort feasibility study of real-time beta-lactam antimicrobial therapeutic drug monitoring in critically ill patients with lower respiratory infection: The TDM-TIME study Save
- Comment on Megat Ramli et al. A Systematic Review: The Role of Artificial Intelligence in Lung Cancer Screening in Detecting Lung Nodules on Chest X-Rays. Diagnostics 2025, 15, 246 Save
- Videolaryngoscopy versus direct laryngoscopy for teaching direct laryngoscopy skills: a systematic review and meta-analysis Save
- A cross-sectional bibliometric analysis of care phases in SCImago’s top five intensive care journals in 2012 and 2022 Save
- Evaluation of five static or dynamic tracheal tube introducers during standard and difficult intubations with C‐MAC® D‐blade videolaryngoscopy in a manikin* Save
- Cautious generosity advised: stop (the lidocaine infusion) before you block (the atrioventricular node) Save
- International consensus-based core outcome set for airway management clinical trials and observational studies: the Airway Terminology and Outcome Measures (ATOM) protocol Save
- Prevalence of Respiratory Viruses in Stable and Acute Asthma Save
- Predictors of treatment REsponse to inhaled corticosteroids (ICS) in Chronic Obstructive pulmonary disease: randomised controlled trials individual participant Data re-Evaluation–protocol of the ICS-RECODE individual participant data meta-analysis Save
- Decoding community-acquired pneumonia Save
- Epidemiology and early predictors of Fabry nephropathy: evaluation of long-term outcomes from a national Fabry centre Save
- Steroids in severe community-acquired pneumonia Save
- Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021 Save
- Unravelling the complexity of ventilator-associated pneumonia Save
- Anaesthetic rooms are no longer needed Save
- Harm during airway management by anaesthetists: its absence in randomised controlled trials does not mean it does not exist Save
- Immunomodulatory drugs in sepsis Save